期刊
JOURNAL OF CLINICAL ANESTHESIA
卷 26, 期 1, 页码 3-17出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jclinane.2013.06.007
关键词
Analgesia; Postoperative; Epidural; Intravenous; Patient-controlled; Nonsmall cell lung carcinoma
资金
- National Institutes of Health [CA016672]
Study Objective: To determine whether postoperative epidural analgesia is associated with better recurrence-free survival and overall survival after lung cancer surgery. Design: Retrospective study. Setting: Academic hospital. Measurements: Data of patients with stage 1, stage 2, and stage 3 nonsmall cell lung cancer, who underwent tumor resection surgery, were studied. Patient data were grouped into three different postoperative pain management interventions; intravenous patient-controlled analgesia, patient-controlled epidural analgesia, and their combination. Univariate and multicovariate Cox proportional hazards models were applied to assess the effects of covariates of interest on overall survival and recurrence-free survival. Main Results: The type of postoperative analgesia used for patients who underwent surgery for nonsmall cell lung cancer did not affect recurrence-free survival or overall survival. However, certain variables, including age >= 65 years, male gender, body mass index >= 25 kg/m(2), ASA physical status 4, and the need for preoperative blood transfusions, pneumonectomy, and postoperative radiation, were associated with decreased recurrence-free survival and overall survival. Conclusions: The type of postoperative analgesia used after surgery for nonsmall cell lung cancer is not associated with better 2-year or 5-year recurrence-free survival or overall survival rates. (c) 2014 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据